Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 1988, 53, 1862-1872
https://doi.org/10.1135/cccc19881862

Quantitative relations between structure and antiinflammatory activity of aryloxoalkanoic acids

Miroslav Kuchař, Eva Maturová, Bohumila Brunová, Jaroslava Grimová, Hana Tomková and Jiří Holubek

Research Institute for Pharmacy and Biochemistry, 130 60 Prague 3

Crossref Cited-by Linking

  • Hessler Filip, Korotvička Aleš, Nečas David, Valterová Irena, Kotora Martin: Syntheses of a Flobufen Metabolite and Dapoxetine Based on Enantioselective Allylation of Aromatic Aldehydes. Eur J Org Chem 2014, 2014, 2543. <https://doi.org/10.1002/ejoc.201301899>
  • Bulej Petr, Kuchař Miroslav, Panajotova Vladimíra, Jegorov Alexandr: Synthesis and activity of 4-(2',4'-difluorobiphenylyl)-2-methylbutyric acid (deoxoflobufen) and its derivatives. J Appl Biomed 2005, 3, 83. <https://doi.org/10.32725/jab.2005.010>
  • Kral Radim, Skalova Lenka, Szotakova Barbora, Babu Yogeeta N., Wsol Vladimir: Stereospecificity of flobufen metabolism in guinea pigs in vitro and in vivo: Phase I of biotransformation. Chirality 2004, 16, 1. <https://doi.org/10.1002/chir.10298>
  • Adamski-Werner Sara L., Palaninathan Satheesh K., Sacchettini James C., Kelly Jeffery W.: Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. J. Med. Chem. 2004, 47, 355. <https://doi.org/10.1021/jm030347n>
  • Olšovská Jana, Flieger Miroslav, Bachechi Fiorella, Messina Antonella, Sinibaldi Massimo: Direct resolution of optically active isomers on chiral packings containing ergoline skeleton. 6. Enantioseparation of profens. Chirality 1999, 11, 291. <https://doi.org/10.1002/(SICI)1520-636X(1999)11:4<291::AID-CHIR6>3.0.CO;2-4>
  • Ol?ovsk� Jana, Flieger Miroslav, Bachechi Fiorella, Messina Antonella, Sinibaldi Massimo: Direct resolution of optically active isomers on chiral packings containing ergoline skeleton. 6. Enantioseparation of profens. Chirality 1999, 11, 291. <https://doi.org/10.1002/(SICI)1520-636X(1999)11:4<291::AID-CHIR6>3.0.CO;2-4>
  • Kvasnicková Eva, Szotáková Barbora, Wsól Vladimír, Trejtnar František, Skálová Lenka, Hais Ivo M., Kuchar Miroslav, Poppová Marie: Metabolic pathways of flobufen — a new antirheumatic and antiarthritic drug. Interspecies comparison. Exp Toxic Pathol 1999, 51, 352. <https://doi.org/10.1016/S0940-2993(99)80020-7>
  • Tesarvá Eva, Gila Martin, Jegorov Alexandr, Uhrová M., Deyl Zdenck: Chiral resolution of flobufen by high performance liquid chromatography and capillary electrophoresis. Biomed Chromatogr 1997, 11, 321. <https://doi.org/10.1002/(SICI)1099-0801(199709)11:5<321::AID-BMC710>3.0.CO;2-J>
  • Tesarv� Eva, Gila Martin, Jegorov Alexandr, Uhrov� M., Deyl Zdenck: Chiral resolution of flobufen by high performance liquid chromatography and capillary electrophoresis. Biomed. Chromatogr. 1997, 11, 321. <https://doi.org/10.1002/(SICI)1099-0801(199709)11:5<321::AID-BMC710>3.0.CO;2-J>
  • Fujita Toshio: Recent Success Stories Leading to Commercializable Bioactive Compounds with the Aid of Traditional QSAR Procedures. Quant. Struct.‐Act. Relat. 1997, 16, 107. <https://doi.org/10.1002/qsar.19970160202>
  • Jegorov Alexandr, Sedmera Petr, Havlíček Vladimír, Hušák Michal, Pakhomova Svetlana, Kratochvíl Bohumil, Kuchař Miroslav, Bulej Petr: Spectroscopic and structural study of flobufen. J FLUORINE CHEM 1995, 73, 213. <https://doi.org/10.1016/0022-1139(94)03220-T>
  • Drsata J., Netopilová M., Navrátolová B., Veselá J.: P60 Pyridoxal enzymes as targets for drugs with various biological activities. Eur J Pharmaceutical Sci 1994, 2, 133. <https://doi.org/10.1016/0928-0987(94)90233-X>
  • Přibová M., Gregorová J., Dršata J.: Inhibition of aromatic amino acid decarboxylase by a group of non-steroidal anti-inflammatory drugs. Pharm Res 1992, 25, 271. <https://doi.org/10.1016/S1043-6618(05)80076-3>